Fingolimod (FTY720), an agonist for S1PRs (S1PR1, S1PR3, S1PR4, and S1PR5), has been approved for multiple sclerosis (MS) by the FDA, showing anti-tumor effects in CRC mouse models [30]. Here, S1PR3 is linked to colorectal carcinoma.